TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data September 13, 1996